ICU Medical Insider Trades
NASDAQ: ICUIHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 160.32 0.00%
Last 12 months
- Purchases
- 0 · $0
- Sales
- 19 · $8.27M
- Shares bought / sold
- 0 / 49.62K
- Net activity
- Net selling $8.3 million
ICU Medical insider activity
Over the last 12 months, ICU Medical insiders reported 78 transactions on SEC Form 4: 0 open-market purchases and 19 sales. Insiders bought $0 and sold $8.3 million worth of stock, for net insider selling of $8.3 million. The largest seller was Bonnell Brian Michael, with $2.7 million in reported sales.
The most recent filing shows Sanzone Virginia Ruth (VP, General Counsel) selling 2,202 shares at $167.67 on Sep 3, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ICUI's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ICUI insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 3, 2026 | Sanzone Virginia RuthVP, General Counsel | Sale | 692 | $118.69K | Form 4 |
| Sep 3, 2026 | Sanzone Virginia RuthVP, General Counsel | Sale | 724 | $122.74K | Form 4 |
| Sep 3, 2026 | Sanzone Virginia RuthVP, General Counsel | Sale | 1,238 | $208.52K | Form 4 |
| Sep 3, 2026 | Sanzone Virginia RuthVP, General Counsel | Sale | 2,202 | $369.20K | Form 4 |
| Sep 1, 2026 | Bonnell Brian MichaelChief Financial Officer | Sale | 6,381 | $1.12M | Form 4 |
| Aug 31, 2026 | Bonnell Brian MichaelChief Financial Officer | Sale | 1,113 | $193.57K | Form 4 |
| Aug 31, 2026 | Bonnell Brian MichaelChief Financial Officer | Sale | 4,568 | $792.29K | Form 4 |
| Aug 31, 2026 | Bonnell Brian MichaelChief Financial Officer | Sale | 1,914 | $329.44K | Form 4 |
| Aug 31, 2026 | Bonnell Brian MichaelChief Financial Officer | Sale | 1,712 | $292.84K | Form 4 |
| Aug 13, 2026 | Woolson DanielVP, GM-Infusion Capital | Sale | 5,417 | $982.26K | Form 4 |
| Aug 12, 2026 | Sousa BenChief Information Officer | Sale | 2,250 | $401.21K | Form 4 |
| Aug 11, 2026 | FINNEY ELISHA WDirector | Sale | 378 | $68.98K | Form 4 |
| Aug 11, 2026 | Voigtlander Christian B.Chief Operating Officer | Sale | 8,929 | $1.63M | Form 4 |
| May 22, 2026 | Woolson DanielPresident | Sale | 2,123 | $280.68K | Form 4 |
| May 14, 2026 | Sanzone Virginia RuthVP, General Counsel | Sale | 2,447 | $303.62K | Form 4 |
| May 13, 2026 | Greenberg David C.Director | Option exercise | 1,254 | — | Form 4 |
| May 13, 2026 | Hoffmeister David FDirector | Option exercise | 1,254 | — | Form 4 |
| May 13, 2026 | Abbey DonaldDirector | Option exercise | 1,254 | — | Form 4 |
| May 13, 2026 | FINNEY ELISHA WDirector | Option exercise | 1,254 | — | Form 4 |
| May 13, 2026 | Hernandez LaurieDirector | Option exercise | 1,254 | — | Form 4 |
| May 13, 2026 | KENNEDY KOLLEEN TDirector | Option exercise | 1,254 | — | Form 4 |
| May 12, 2026 | Greenberg David C.Director | Sale | 2,424 | $297.93K | Form 4 |
| May 12, 2026 | Greenberg David C.Director | Option exercise | 2,424 | $244.97K | Form 4 |
| Mar 25, 2026 | Abbey DonaldDirector | other | 704 | — | Form 4 |
| Mar 15, 2026 | Bonnell Brian MichaelChief Financial Officer | Tax withholding | 1,795 | $225.90K | Form 4 |
| Mar 15, 2026 | Bonnell Brian MichaelChief Financial Officer | Option exercise | 3,248 | — | Form 4 |
| Mar 15, 2026 | Bonnell Brian MichaelChief Financial Officer | Tax withholding | 5,800 | $729.93K | Form 4 |
| Mar 15, 2026 | Bonnell Brian MichaelChief Financial Officer | Option exercise | 11,400 | — | Form 4 |
| Mar 15, 2026 | Jain VivekChairman and CEO | Tax withholding | 2,693 | $338.91K | Form 4 |
| Mar 15, 2026 | Jain VivekChairman and CEO | Option exercise | 4,872 | — | Form 4 |
| Mar 15, 2026 | Jain VivekChairman and CEO | Tax withholding | 9,452 | $1.19M | Form 4 |
| Mar 15, 2026 | Jain VivekChairman and CEO | Option exercise | 17,100 | — | Form 4 |
| Mar 15, 2026 | Sanzone Virginia RuthVP, General Counsel | Tax withholding | 897 | $112.89K | Form 4 |
| Mar 15, 2026 | Sanzone Virginia RuthVP, General Counsel | Option exercise | 1,624 | — | Form 4 |
| Mar 15, 2026 | Sanzone Virginia RuthVP, General Counsel | Tax withholding | 3,150 | $396.43K | Form 4 |
| Mar 15, 2026 | Sanzone Virginia RuthVP, General Counsel | Option exercise | 5,700 | — | Form 4 |
| Mar 15, 2026 | Sousa BenChief Information Officer | Tax withholding | 718 | $90.36K | Form 4 |
| Mar 15, 2026 | Sousa BenChief Information Officer | Option exercise | 1,300 | — | Form 4 |
| Mar 15, 2026 | Woolson DanielVP, GM-Infusion Capital | Tax withholding | 1,295 | $162.98K | Form 4 |
| Mar 15, 2026 | Woolson DanielVP, GM-Infusion Capital | Option exercise | 2,924 | — | Form 4 |
| Mar 15, 2026 | Voigtlander Christian B.Chief Operating Officer | Tax withholding | 1,795 | $225.90K | Form 4 |
| Mar 15, 2026 | Voigtlander Christian B.Chief Operating Officer | Option exercise | 3,248 | — | Form 4 |
| Mar 15, 2026 | Voigtlander Christian B.Chief Operating Officer | Tax withholding | 6,301 | $792.98K | Form 4 |
| Mar 15, 2026 | Voigtlander Christian B.Chief Operating Officer | Option exercise | 11,400 | — | Form 4 |
| Mar 8, 2026 | Voigtlander Christian B.Chief Operating Officer | Tax withholding | 39,667 | $5.24M | Form 4 |
| Mar 8, 2026 | Voigtlander Christian B.Chief Operating Officer | Option exercise | 71,757 | — | Form 4 |
| Mar 8, 2026 | Woolson DanielVP, GM-Infusion Capital | Tax withholding | 630 | $83.16K | Form 4 |
| Mar 8, 2026 | Woolson DanielVP, GM-Infusion Capital | Option exercise | 2,153 | — | Form 4 |
| Mar 8, 2026 | Woolson DanielVP, GM-Infusion Capital | Tax withholding | 6,877 | $907.76K | Form 4 |
| Mar 8, 2026 | Woolson DanielVP, GM-Infusion Capital | Option exercise | 16,147 | — | Form 4 |
| Mar 8, 2026 | Sanzone Virginia RuthVP, General Counsel | Tax withholding | 1,762 | $232.58K | Form 4 |
| Mar 8, 2026 | Sanzone Virginia RuthVP, General Counsel | Option exercise | 3,189 | — | Form 4 |
| Mar 8, 2026 | Sanzone Virginia RuthVP, General Counsel | Tax withholding | 13,221 | $1.75M | Form 4 |
| Mar 8, 2026 | Sanzone Virginia RuthVP, General Counsel | Option exercise | 23,917 | — | Form 4 |
| Mar 8, 2026 | Sousa BenChief Information Officer | Tax withholding | 529 | $69.83K | Form 4 |
| Mar 8, 2026 | Sousa BenChief Information Officer | Option exercise | 957 | — | Form 4 |
| Mar 8, 2026 | Sousa BenChief Information Officer | Tax withholding | 3,967 | $523.64K | Form 4 |
| Mar 8, 2026 | Sousa BenChief Information Officer | Option exercise | 7,177 | — | Form 4 |
| Mar 8, 2026 | Jain VivekChairman and CEO | Tax withholding | 59,500 | $7.85M | Form 4 |
| Mar 8, 2026 | Jain VivekChairman and CEO | Option exercise | 107,635 | — | Form 4 |
| Mar 8, 2026 | Bonnell Brian MichaelChief Financial Officer | Tax withholding | 39,667 | $5.24M | Form 4 |
| Mar 8, 2026 | Bonnell Brian MichaelChief Financial Officer | Option exercise | 71,757 | — | Form 4 |
| Mar 7, 2026 | Voigtlander Christian B.Chief Operating Officer | Tax withholding | 1,946 | $256.87K | Form 4 |
| Mar 7, 2026 | Voigtlander Christian B.Chief Operating Officer | Option exercise | 3,522 | — | Form 4 |
| Mar 7, 2026 | Woolson DanielVP, GM-Infusion Capital | Tax withholding | 702 | $92.66K | Form 4 |
| Mar 7, 2026 | Woolson DanielVP, GM-Infusion Capital | Option exercise | 1,585 | — | Form 4 |
| Mar 7, 2026 | Sanzone Virginia RuthVP, General Counsel | Tax withholding | 1,297 | $171.20K | Form 4 |
| Mar 7, 2026 | Sanzone Virginia RuthVP, General Counsel | Option exercise | 2,348 | — | Form 4 |
| Mar 7, 2026 | Sousa BenChief Information Officer | Tax withholding | 782 | $103.22K | Form 4 |
| Mar 7, 2026 | Sousa BenChief Information Officer | Option exercise | 1,409 | — | Form 4 |
| Mar 7, 2026 | Jain VivekChairman and CEO | Tax withholding | 2,919 | — | Form 4 |
| Mar 7, 2026 | Jain VivekChairman and CEO | Option exercise | 5,282 | — | Form 4 |
| Mar 7, 2026 | Bonnell Brian MichaelChief Financial Officer | Tax withholding | 1,263 | — | Form 4 |
| Mar 7, 2026 | Bonnell Brian MichaelChief Financial Officer | Option exercise | 3,522 | — | Form 4 |
| Nov 25, 2025 | Woolson DanielVP, GM-Infusion Capital | Sale | 2,897 | $441.36K | Form 4 |
| Nov 11, 2025 | Sanzone Virginia RuthVP, General Counsel | Sale | 930 | $132.38K | Form 4 |
| Nov 11, 2025 | FINNEY ELISHA WDirector | Sale | 1,285 | $180.44K | Form 4 |
| Nov 11, 2025 | FINNEY ELISHA WDirector | Option exercise | 1,285 | $133.33K | Form 4 |
| Sep 12, 2025 | Jain VivekChairman and CEO | Gift | 63,641 | — | Form 4 |
| Sep 12, 2025 | Jain VivekChairman and CEO | Gift | 63,641 | — | Form 4 |
| Aug 27, 2025 | Greenberg David C.Director | Buy | 598 | $75.76K | Form 4 |
| Aug 27, 2025 | Greenberg David C.Director | Buy | 602 | $75.94K | Form 4 |
| Aug 14, 2025 | Jain VivekChairman and CEO | Buy | 19,551 | $2.21M | Form 4 |
| Aug 14, 2025 | Jain VivekChairman and CEO | Buy | 2,378 | $266.61K | Form 4 |
| May 30, 2025 | Sanzone Virginia RuthVP, General Counsel | Sale | 700 | $93.54K | Form 4 |
| May 28, 2025 | Voigtlander Christian B.Chief Operating Officer | Sale | 4,985 | $640.58K | Form 4 |
| May 28, 2025 | Voigtlander Christian B.Chief Operating Officer | Option exercise | 5,560 | $538.37K | Form 4 |
| May 27, 2025 | Voigtlander Christian B.Chief Operating Officer | Sale | 4,945 | $647.79K | Form 4 |
| May 27, 2025 | Voigtlander Christian B.Chief Operating Officer | Option exercise | 5,555 | $537.89K | Form 4 |
| May 23, 2025 | Voigtlander Christian B.Chief Operating Officer | Sale | 4,959 | $644.67K | Form 4 |
| May 23, 2025 | Voigtlander Christian B.Chief Operating Officer | Option exercise | 5,555 | $537.89K | Form 4 |
| May 22, 2025 | Voigtlander Christian B.Chief Operating Officer | Sale | 4,959 | $644.83K | Form 4 |
| May 22, 2025 | Voigtlander Christian B.Chief Operating Officer | Option exercise | 5,555 | $537.89K | Form 4 |
| May 21, 2025 | Voigtlander Christian B.Chief Operating Officer | Sale | 4,917 | $653.96K | Form 4 |
| May 21, 2025 | Voigtlander Christian B.Chief Operating Officer | Option exercise | 5,555 | $537.89K | Form 4 |
| May 20, 2025 | Voigtlander Christian B.Chief Operating Officer | Sale | 4,871 | $667.88K | Form 4 |
| May 20, 2025 | Voigtlander Christian B.Chief Operating Officer | Option exercise | 5,555 | $537.89K | Form 4 |
| May 19, 2025 | Voigtlander Christian B.Chief Operating Officer | Sale | 5,555 | $766.61K | Form 4 |
| May 19, 2025 | Voigtlander Christian B.Chief Operating Officer | Option exercise | 5,555 | $537.89K | Form 4 |
| May 19, 2025 | FINNEY ELISHA WDirector | Sale | 600 | $83.35K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4